1. Home
  2. Analysis
  3. Duragesic
  4. Intracranial-aneurysm

Duragesic and Intracranial aneurysm - a phase IV clinical study of FDA data

Summary:

Intracranial aneurysm is reported as a side effect among people who take Duragesic (fentanyl), especially for people who are female, 60+ old, also take Xanax, and have Stress and anxiety.

The phase IV clinical study analyzes which people have Intracranial aneurysm when taking Duragesic. It is created by eHealthMe based on reports of 66,376 people who have side effects when taking Duragesic from the FDA, and is updated regularly.

What is Duragesic?

Duragesic has active ingredients of fentanyl. eHealthMe is studying from 66,597 Duragesic users. Check the latest studies of Duragesic.

What is Intracranial aneurysm?

Intracranial aneurysm (bulging, weak area in the wall of a cranial artery) is found to be associated with 484 drugs and 529 conditions by eHealthMe. Check the latest studies of Intracranial aneurysm.

On Jun, 13, 2026

66,376 people reported to have side effects when taking Duragesic.
Among them, 24 people (0.04%) have Intracranial aneurysm.

Could Duragesic cause Intracranial aneurysm?

Among these 24 people:

What is the gender of people who have Intracranial aneurysm when taking Duragesic? *

  • female: 75 %
  • male: 25 %

What is the age of people who have Intracranial aneurysm when taking Duragesic? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 5.56 %
  • 30-39: 0.0 %
  • 40-49: 16.67 %
  • 50-59: 38.89 %
  • 60+: 38.89 %

What are other drugs people take besides Duragesic? *

  1. Xanax: 11 people, 45.83%
  2. Singulair: 7 people, 29.17%
  3. Ambien: 7 people, 29.17%
  4. Oxycontin: 7 people, 29.17%
  5. Baclofen: 6 people, 25.00%
  6. Ranitidine: 5 people, 20.83%
  7. Mobic: 5 people, 20.83%
  8. Dexamethasone: 4 people, 16.67%
  9. Effexor: 4 people, 16.67%
  10. Paclitaxel: 4 people, 16.67%

What are other side effects people have besides Intracranial aneurysm? *

  1. Headache (pain in head): 11 people, 45.83%
  2. Dyspnea (difficult or laboured breathing): 10 people, 41.67%
  3. Pain: 9 people, 37.50%
  4. High Blood Pressure: 9 people, 37.50%
  5. Osteoporosis (bones weak and more likely to break): 9 people, 37.50%
  6. Hyperhidrosis (abnormally increased sweating): 6 people, 25.00%
  7. Joint Pain: 6 people, 25.00%
  8. Malaise (a feeling of general discomfort or uneasiness): 6 people, 25.00%
  9. Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 6 people, 25.00%
  10. Diarrhea: 6 people, 25.00%

What are the existing conditions these people have? *

  1. Stress And Anxiety: 10 people, 41.67%
  2. Back Pain: 9 people, 37.50%
  3. Pain: 9 people, 37.50%
  4. Muscle Spasms (muscle contraction): 6 people, 25.00%
  5. High Blood Pressure: 6 people, 25.00%
  6. Depression: 5 people, 20.83%
  7. Metastases To Bone (cancer spreads to bone): 4 people, 16.67%
  8. Hormone Level Abnormal: 3 people, 12.50%
  9. Gastric Disorder (disease of stomach): 3 people, 12.50%
  10. Breakthrough Pain: 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Duragesic and have Intracranial aneurysm?

- Check whether Intracranial aneurysm is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Duragesic:

Intracranial aneurysm treatments and more:

How severe was Intracranial aneurysm and when was it recovered:

Expand to all the drugs that have ingredients of fentanyl:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Duragesic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Intracranial aneurysm:

Browse all the conditions that are associated with Intracranial aneurysm:

How the study uses the data?

The study uses data from the FDA. It is based on fentanyl (the active ingredients of Duragesic) and Duragesic (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.